---

COVID-19 and the clinical chemistry laboratory: experience from a dedicated COVID-19 laboratory

---

Review Article

Author Details : R Vinayagamoorthi*, Pooja Dhiman, S Baskaran

Volume : 7, Issue : 3, Year : 2020

Article Page : 302-306

https://doi.org/10.18231/j.ijcbr.2020.065

Suggest article by email

Get Permission

---

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic has presented major challenges to health
care workers including laboratory professionals. Clinical laboratories play a critical role in this challenging
environment by providing information to clinicians regarding prognosis, disease severity, and response
to therapy apart from the diagnosis of COVID-19. Clinical chemistry laboratories inhabit central role in
the management of COVID-19 through assessing the biochemical and inflammatory profile. It has been
emphasised by many health organisations that health care workers are at high risk with COVID-19 outbreak.
Sharing and updating of personal experiences regarding the laboratory safety is essential to minimise
the risk of laboratory personal working in this crisis. Hence, in this review article, we documented our
experiences in setting up a dedicated COVID-19 clinical chemistry laboratory and the biosafety aspects
followed in our setup. This review article will provide information to clinical biochemists and laboratory
professionals to establish a safety laboratory environment during this COVID-19 pandemic.

Keywords: Biochemical parameters, Biosafety, Coronavirus disease 2019 (COVID19), Clinical chemistry Laboratory,
Laboratory professionals.

How to cite : Vinayagamoorthi R , Dhiman P , Baskaran S , COVID-19 and the clinical chemistry laboratory: experience from a dedicated COVID-19 laboratory. Int J Clin Biochem Res 2020;7(3):302-306

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.